Matica Biotechnology is a viral vector Contract Development and Manufacturing Organization (CDMO) that leverages advanced technologies at its purpose-built cGMP facility. With industry-leading expertise in process development, assay development, and cGMP manufacturing, Matica Bio serves as a trusted partner, seamlessly supporting its clients with streamlined operations throughout every stage of projects. Collaborating across five Matica sites worldwide, Matica Bio delivers excellence in the CDMO domain through innovations such as MatiMax™ proprietary cell lines, in-line process monitoring, and single-use technologies.

Services include:
– Cell and Gene Therapy
– Drug Substance Manufacturing (API)
– Drug Product Formulation (FDF)
– Research & Development
– Clinical Trial Materials
– Analytical Methods Development

Matica Biotechnology is dedicated to providing comprehensive solutions to the pharmaceutical industry through its diverse range of services and innovative approaches. For more information, visit maticabio.com.